{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:10:34Z","timestamp":1771575034740,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12288-025-02095-8","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T03:47:14Z","timestamp":1754106434000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Differences Between P190 and P210 BCR::ABL1 in Patients with Philadelphia-Positive B-cell Acute Lymphoblastic Leukemia"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2762-8573","authenticated-orcid":false,"given":"M. S.","family":"Pepeler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ozt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Okumus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Dal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Dilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sar\u0131bacak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ayli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ceran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"\u00d6zet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Da\u011fdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"issue":"5","key":"2095_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11912-012-0247-7","volume":"14","author":"T Liu-Dumlao","year":"2012","unstructured":"Liu-Dumlao T, Kantarjian H, Thomas DA, O\u2019Brien S, Ravandi F (2012) Philadelphia-positive acute lymphoblastic leukemia: current treatment options. Curr Oncol Rep 14(5):387\u2013394. https:\/\/doi.org\/10.1007\/s11912-012-0247-7","journal-title":"Curr Oncol Rep"},{"key":"2095_CR2","unstructured":"Haider MZ, Anwer F (2024) Genetics, Philadelphia Chromosome. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560689\/"},{"issue":"10","key":"2095_CR3","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96(10):3343\u20133356","journal-title":"Blood"},{"issue":"2","key":"2095_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1525-1578(10)60454-0","volume":"5","author":"AL Nashed","year":"2003","unstructured":"Nashed AL, Rao KW, Gulley ML (2003) Clinical applications of BCR-ABL molecular testing in acute leukemia. J Mol Diagn 5(2):63\u201372. https:\/\/doi.org\/10.1016\/S1525-1578(10)60454-0","journal-title":"J Mol Diagn"},{"issue":"17","key":"2095_CR5","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1002\/cncr.25978","volume":"117","author":"J Jaso","year":"2011","unstructured":"Jaso J, Thomas DA, Cunningham K, Jorgensen JL, Kantarjian HM, Medeiros LJ, Wang SA (2011) Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors. Cancer 117(17):4009\u20134017. https:\/\/doi.org\/10.1002\/cncr.25978","journal-title":"Cancer"},{"issue":"7","key":"2095_CR6","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/leu.2017.36","volume":"31","author":"S Reckel","year":"2017","unstructured":"Reckel S, Hamelin R, Georgeon S, Armand F, Jolliet Q, Chiappe D, Moniatte M, Hantschel O (2017) Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics. Leukemia 31(7):1502\u20131512. https:\/\/doi.org\/10.1038\/leu.2017.36","journal-title":"Leukemia"},{"issue":"7","key":"2095_CR7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/leu.2017.61","volume":"31","author":"JA Cutler","year":"2017","unstructured":"Cutler JA, Tahir R, Sreenivasamurthy SK, Mitchell C, Renuse S, Nirujogi RS, Patil AH, Heydarian M, Wong X, Wu X, Huang TC, Kim MS, Reddy KL, Pandey A (2017) Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and phosphoproteome analysis. Leukemia 31(7):1513\u20131524. https:\/\/doi.org\/10.1038\/leu.2017.61","journal-title":"Leukemia"},{"key":"2095_CR8","doi-asserted-by":"crossref","unstructured":"Zhang L, Habeebu SSM, Li W (2022) Prognostic and Predictive Biomarkers in Precursor B-cell Acute Lymphoblastic Leukemia. In: Li W, editor. Leukemia [Internet]. Brisbane (AU): Exon Publications. Chapter 10","DOI":"10.36255\/exon-publications-leukemia-biomarkers-lymphoblastic-leukemia"},{"issue":"1","key":"2095_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40164-022-00265-2","volume":"11","author":"T Shi","year":"2022","unstructured":"Shi T, Xie M, Chen L, Yuan W, Wang Y, Huang X, Xie W, Meng H, Lou Y, Yu W, Tong H, Ye X, Huang J, Jin J, Zhu H (2022) Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era. Exp Hematol Oncol 11(1):13. https:\/\/doi.org\/10.1186\/s40164-022-00265-2","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"2095_CR10","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3324\/haematol.2020.260935","volume":"106","author":"S Chiaretti","year":"2021","unstructured":"Chiaretti S, Ansuinelli M, Vitale A, Elia L, Matarazzo M, Piciocchi A, Fazi P, Di Raimondo F, Santoro L, Fabbiano F, Califano C, Martinelli G, Ronco F, Ferrara F, Cascavilla N, Bigazzi C, Tedeschi A, Sica S, Di Renzo N, Melpignano A, Beltrami G, Vignetti M, Foa R (2021) A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol. Haematologica 106(7):1828\u20131838. https:\/\/doi.org\/10.3324\/haematol.2020.260935","journal-title":"Haematologica"},{"key":"2095_CR11","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMoa2016272","volume":"383","author":"R Fo\u00e0","year":"2020","unstructured":"Fo\u00e0 R, Bassan R, Vitale A, Elia L, Piciocchi A, Puzzolo MC, Canichella M, Viero P, Ferrara F, Lunghi M, Fabbiano F, Bonifacio M, Fracchiolla N, Di Bartolomeo P, Mancino A, De Propris MS, Vignetti M, Guarini A, Rambaldi A, Chiaretti S (2020) GIMEMA Investigators. Dasatinib-Blinatumomab for Ph-positive acute lymphoblastic leukemia in adults. N Engl J Med 383:1613\u20131623. https:\/\/doi.org\/10.1056\/NEJMoa2016272","journal-title":"N Engl J Med"},{"issue":"12","key":"2095_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ajh.21291","volume":"83","author":"JM Klco","year":"2008","unstructured":"Klco JM, Kreisel FH, Zehnbauer BA, Kulkarni S, Hassan A, Frater JL (2008) The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives. Am J Hematol 83(12):901\u2013907. https:\/\/doi.org\/10.1002\/ajh.21291","journal-title":"Am J Hematol"},{"issue":"3","key":"2095_CR13","first-page":"377","volume":"91","author":"G Cimino","year":"2006","unstructured":"Cimino G, Pane F, Elia L, Finolezzi E, Fazi P, Annino L, Meloni G, Mancini M, Tedeschi A, Di Raimondo F, Specchia G, Fioritoni G, Leoni P, Cuneo A, Mecucci C, Saglio G, Mandelli F, Fo\u00e0 R (2006) GIMEMA leukemia working party. The role of BCR\/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial. Haematologica 91(3):377\u2013380","journal-title":"Haematologica"},{"issue":"5","key":"2095_CR14","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1182\/blood.v99.5.1536","volume":"99","author":"B Gleissner","year":"2002","unstructured":"Gleissner B, G\u00f6kbuget N, Bartram CR, Janssen B, Rieder H, Janssen JW, Fonatsch C, Heyll A, Voliotis D, Beck J, Lipp T, Munzert G, Maurer J, Hoelzer D, Thiel E (2002) German multicenter trials of adult acute lymphoblastic leukemia study group. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood 99(5):1536\u20131543. https:\/\/doi.org\/10.1182\/blood.v99.5.1536","journal-title":"Blood"},{"issue":"6","key":"2095_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1182\/blood-2016-02-700153","volume":"128","author":"P Rousselot","year":"2016","unstructured":"Rousselot P, Coud\u00e9 MM, Gokbuget N, Gambacorti Passerini C, Hayette S, Cayuela JM, Huguet F, Leguay T, Chevallier P, Salanoubat C, Bonmati C, Alexis M, Hunault M, Glaisner S, Agape P, Berthou C, Jourdan E, Fernandes J, Sutton L, Banos A, Reman O, Lioure B, Thomas X, Ifrah N, Lafage-Pochitaloff M, Bornand A, Morisset L, Robin V, Pfeifer H, Delannoy A, Ribera J, Bassan R, Delord M, Hoelzer D, Dombret H, Ottmann OG (2016) European working group on adult ALL (EWALL) group. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL. Blood 128(6):774\u2013782. https:\/\/doi.org\/10.1182\/blood-2016-02-700153","journal-title":"Blood"},{"issue":"suppl 5","key":"2095_CR16","doi-asserted-by":"publisher","first-page":"v69","DOI":"10.1093\/annonc\/mdw025","volume":"27","author":"D Hoelzer","year":"2016","unstructured":"Hoelzer D, Bassan R, Dombret H, Fielding A, Ribera JM, Buske C (2016) ESMO guidelines committee. Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v69\u2013v82. https:\/\/doi.org\/10.1093\/annonc\/mdw025","journal-title":"Ann Oncol"},{"issue":"11","key":"2095_CR17","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.mayocp.2016.09.010","volume":"91","author":"S Paul","year":"2016","unstructured":"Paul S, Kantarjian H, Jabbour EJ (2016) Adult acute lymphoblastic leukemia. Mayo Clin Proc 91(11):1645\u20131666. https:\/\/doi.org\/10.1016\/j.mayocp.2016.09.010","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"2095_CR18","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","volume":"106","author":"JM Rowe","year":"2005","unstructured":"Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM, Lazarus HM, Franklin IM, Litzow MR, Ciobanu N, Prentice HG, Durrant J, Tallman MS, Goldstone AH (2005) ECOG; MRC\/NCRI Adult leukemia working party. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993. Blood 106(12):3760\u20133767","journal-title":"Blood"},{"issue":"5","key":"2095_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bjhh.2014.07.016","volume":"36","author":"ID Azevedo","year":"2014","unstructured":"Azevedo ID, Silva RM, Vasconcelos AV, Neves WB, Melo FC, Melo RA (2014) Frequency of p190 and p210 BCR-ABL rearrangements and survival in Brazilian adult patients with acute lymphoblastic leukemia. Rev Bras Hematol Hemoter 36(5):351\u2013355. https:\/\/doi.org\/10.1016\/j.bjhh.2014.07.016","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"2095_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40164-020-00189-9","volume":"9","author":"L Li","year":"2020","unstructured":"Li L, Wang Y (2020) Recent updates for antibody therapy for acute lymphoblastic leukemia. Exp Hematol Oncol 9(1):33. https:\/\/doi.org\/10.1186\/s40164-020-00189-9","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2095_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-020-00905-2","volume":"13","author":"B Samra","year":"2020","unstructured":"Samra B, Jabbour E, Ravandi F, Kantarjian H, Short NJ (2020) Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions. J Hematol Oncol 13(1):70. https:\/\/doi.org\/10.1186\/s13045-020-00905-2","journal-title":"J Hematol Oncol"},{"issue":"7","key":"2095_CR22","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","volume":"100","author":"H Dombret","year":"2002","unstructured":"Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X et al (2002) Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia\u2014results of the prospective multicenter LALA-94 trial. Blood 100(7):2357\u20132366. https:\/\/doi.org\/10.1182\/blood-2002-03-0704","journal-title":"Blood"},{"issue":"18","key":"2095_CR23","doi-asserted-by":"publisher","first-page":"100352","DOI":"10.1016\/j.lrr.2022.100352","volume":"7","author":"R Takiar","year":"2022","unstructured":"Takiar R, Foucar CE, Perissinotti AJ, Marini BL, Benitez-Colon L, Burke PW, Bixby DL (2022) Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation\u2014a single institution experience. Leuk Res Rep 7(18):100352. https:\/\/doi.org\/10.1016\/j.lrr.2022.100352","journal-title":"Leuk Res Rep"},{"issue":"3","key":"2095_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/ijms21031054","volume":"21","author":"A Kruse","year":"2020","unstructured":"Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, Ogana H, Wang W, Lee R, Gang EJ, Khazal S, Kim YM (2020) Minimal residual disease detection in acute lymphoblastic leukemia. Int J Mol Sci 21(3):1054. https:\/\/doi.org\/10.3390\/ijms21031054","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2095_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.annonc.2023.09.3112","volume":"35","author":"D Hoelzer","year":"2024","unstructured":"Hoelzer D, Bassan R, Boissel N, Roddie C, Ribera JM, Jerkeman M (2024) ESMO guidelines committee. Esmo clinical practice guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia. Ann Oncol 35(1):15\u201328. https:\/\/doi.org\/10.1016\/j.annonc.2023.09.3112","journal-title":"Ann Oncol"},{"issue":"19","key":"2095_CR26","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood.2023023568","volume":"143","author":"N G\u00f6kbuget","year":"2024","unstructured":"G\u00f6kbuget N, Boissel N, Chiaretti S, Dombret H, Doubek M, Fielding A, Fo\u00e0 R, Giebel S, Hoelzer D, Hunault M, Marks DI, Martinelli G, Ottmann O, Rijneveld A, Rousselot P, Ribera J, Bassan R (2024) Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143(19):1903\u20131930. https:\/\/doi.org\/10.1182\/blood.2023023568","journal-title":"Blood"},{"issue":"3","key":"2095_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.32322\/jhsm.735979","volume":"3","author":"TN Yi\u011feno\u011flu","year":"2020","unstructured":"Yi\u011feno\u011flu TN, Bahsi T, Erdem HB, D\u00fczkale N, Uncu Ulu B, Iskender D, \u00c7akar MK, Dal MS, Altuntas F (2020) P210 breakpoint is associated with less minimal residual disease compared to p190 breakpoint in acute lymphoblastic leukemia patients with Philadelphia chromosome. J Health Sci Med 3(3):307\u2013311. https:\/\/doi.org\/10.32322\/jhsm.735979","journal-title":"J Health Sci Med"},{"issue":"63","key":"2095_CR28","doi-asserted-by":"publisher","first-page":"107022","DOI":"10.18632\/oncotarget.22206","volume":"8","author":"G Yu","year":"2017","unstructured":"Yu G, Chen F, Yin C, Liu Q, Sun J, Xuan L et al (2017) Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia. Oncotarget 8(63):107022\u2013107032. https:\/\/doi.org\/10.18632\/oncotarget.22206","journal-title":"Oncotarget"},{"issue":"12","key":"2095_CR29","doi-asserted-by":"publisher","first-page":"e0243657","DOI":"10.1371\/journal.pone.0243657","volume":"15","author":"W Zhang","year":"2020","unstructured":"Zhang W, Kuang P, Liu T (2020) Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: a meta-analysis. PLoS ONE 15(12):e0243657. https:\/\/doi.org\/10.1371\/journal.pone.0243657","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1007\/s12288-026-02348-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000}}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-025-02095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-025-02095-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-025-02095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:35:36Z","timestamp":1771572936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-025-02095-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1007\/s12288-025-02095-8","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to update co-author name.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12288-026-02348-0","URL":"https:\/\/doi.org\/10.1007\/s12288-026-02348-0","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}